izpis_h1_title_alt

The endocrine manifestations of adults with spinal muscular atrophy
ID Rakuša, Matej (Avtor), ID Koritnik, Blaž (Avtor), ID Leonardis, Lea (Avtor), ID Goričar, Katja (Avtor), ID Rudolf, Tjaša (Avtor), ID Firbas, Dejan (Avtor), ID Snoj, Žiga (Avtor), ID Jensterle Sever, Mojca (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,37 MB)
MD5: 1B3AFE30FF4936AF7335893F92F1F406
URLURL - Izvorni URL, za dostop obiščite https://onlinelibrary.wiley.com/doi/10.1002/mus.28275 Povezava se odpre v novem oknu

Izvleček
Introduction/Aims: Changes in body composition in patients with spinal muscular atrophy (SMA) can cause endocrine abnormalities that are insufficiently studied in adults. We aimed to assess the endocrine profile in a cohort of adults with SMA. Second, we compared body composition and endocrine profiles between nonambulatory and ambulatory patients and between different types of SMA. Methods: The cross-sectional study included 29 SMA patients (18 [62.1%] males and 11 [37.9%] females) of median age 44 (IQR 30–51.5) years with type 2, 3, or 4. Body composition was measured by bioimpedance. Morning blood samples were drawn for glycated hemoglobin (HbA1c), lipid profile, testosterone, cortisol, and insulin-like growth factor-1 (IGF-1). Blood glucose, insulin, and beta-hydroxybutyrate (BHB) were measured during a 75 g oral glucose tolerance test. The homeostatic model assessment for insulin resistance index was calculated. Results: In total, 75.9% of patients had increased fat mass (FM), with 51.7% having an increase despite normal body mass index. Ambulation was the most important discriminating factor of body composition. 93.1% of patients had metabolic abnormalities, including hyperglycemia, insulin resistance, and dyslipidemia. Increased BHB, a marker of ketosis, was present in more than a third of patients. Functional hypogonadism was present in half of male patients. Testosterone and IGF-1 negatively correlated with FM. Discussion: Adult patients with SMA had abnormal body composition and highly prevalent metabolic disturbances that might increase cardiometabolic risk. Because treatments have modified the course of SMA, it is important to investigate whether these observations translate into clinically relevant outcomes.

Jezik:Angleški jezik
Ključne besede:spinal muscular atrophy, endocrine manifestations, adults, beta-hydroxybutyrate, body composition, glucose metabolism, hypogonadism, lipid profile
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:Str. 1230–1239
Številčenje:Vol. 70, iss. 6
PID:20.500.12556/RUL-164877 Povezava se odpre v novem oknu
UDK:616.8
ISSN pri članku:0148-639X
DOI:10.1002/mus.28275 Povezava se odpre v novem oknu
COBISS.SI-ID:210399491 Povezava se odpre v novem oknu
Datum objave v RUL:14.11.2024
Število ogledov:64
Število prenosov:24
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Muscle & nerve
Skrajšan naslov:Muscle nerve
Založnik:Wiley
ISSN:0148-639X
COBISS.SI-ID:25987584 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc/4.0/deed.sl
Opis:Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:spinalna mišična atrofija, endokrini simptomi, odrasli

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj